Linerixibat for treating pruritus in people with primary biliary cholangitis [ID6265]
Awaiting development
Reference number: GID-TA11307
Expected publication date:
Please note that following on from a request received from the company, the timelines for this appraisal have been revised and the appraisal is now anticipated to begin in late September 2025. The deadline for submissions is expected in approximately late November 2025.
These timings are based on a request from the company to reschedule the initial date set by NICE, in order to facilitate a suitably comprehensive and robust submission.